Cargando…
Narrowing the focus: Therapeutic cell surface targets for refractory triple-negative breast cancer
Triple-negative breast cancer (TNBC) is defined as a type of breast cancer with lack of expression of estrogen receptor, progesterone receptor and human epidermal growth factor 2 protein. In comparison to other types of breast cancer, TNBC characterizes for its aggressive behavior, more prone to ear...
Autores principales: | Tafreshi, Narges K, Morse, David L, Lee, Marie Catherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186233/ https://www.ncbi.nlm.nih.gov/pubmed/32355639 http://dx.doi.org/10.5306/wjco.v11.i4.169 |
Ejemplares similares
-
Targeted Therapeutic Strategies for Triple-Negative Breast Cancer
por: Li, Ying, et al.
Publicado: (2021) -
CAPER as a therapeutic target for triple negative breast cancer
por: Campbell, Mallory C., et al.
Publicado: (2018) -
Molecular Targets and Promising Therapeutics of Triple-Negative Breast Cancer
por: Ryu, Won-Ji, et al.
Publicado: (2021) -
Pathogenesis and Potential Therapeutic Targets for Triple-Negative Breast Cancer
por: Li, Chia-Jung, et al.
Publicado: (2021) -
Ferroptosis and triple-negative breast cancer: Potential therapeutic targets
por: Xu, Na, et al.
Publicado: (2022)